Trinity compound research profile
Cartalax
Cartalax is a very short lab-made peptide, made of just three amino acids (alanine, glutamate, and aspartate, shortened to "AED"). It comes from a Russian...
Research overview
Cartalax is a very short lab-made peptide, made of just three amino acids (alanine, glutamate, and aspartate, shortened to "AED"). It comes from a Russian research program started by scientist Vladimir Khavinson, who developed a whole family of short peptides believed to help regulate genes as people age (Int J Mol Sci 2023).
Mechanism under study
Unlike most drugs that lock onto a specific "receptor" switch on a cell's surface, Cartalax is thought to work more subtly — by nudging which genes inside a cell get turned on or off. In lab studies, it has been shown to activate certain genes tied to inflammation control and turn on other genes involved in building cartilage — the smooth, cushiony tissue found in joints — including genes that make key structural proteins in cartilage (PMID 37782646).
Human evidence summary
According to the existing research, there are no published human clinical trials of Cartalax specifically. A related, broader treatment (called the cartilage polypeptide complex, of which Cartalax's active ingredient is one part) has reportedly entered a Phase 2 study in Russia, but detailed results for Cartalax itself weren't found (Int J Mol Sci 2023).
Preclinical evidence summary
Most of the actual lab evidence comes from cell cultures rather than living animals — cartilage cells (chondrocytes) treated with Cartalax's active ingredient showed improvements in markers linked to cellular aging (PMID 37356100), and aging skin cells from rats showed changes in markers related to cell growth and survival (Int J Mol Sci 2023). An important limitation: virtually all of this research comes from one single research group, much of it published in Russian-language journals, meaning there's been little to no independent confirmation by other scientists.
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.